202 related articles for article (PubMed ID: 35304506)
1. Clinical associations of ESR2 (estrogen receptor beta) expression across thousands of primary breast tumors.
Dalal H; Dahlgren M; Gladchuk S; Brueffer C; Gruvberger-Saal SK; Saal LH
Sci Rep; 2022 Mar; 12(1):4696. PubMed ID: 35304506
[TBL] [Abstract][Full Text] [Related]
2. TP53 Status as a Determinant of Pro- vs Anti-Tumorigenic Effects of Estrogen Receptor-Beta in Breast Cancer.
Mukhopadhyay UK; Oturkar CC; Adams C; Wickramasekera N; Bansal S; Medisetty R; Miller A; Swetzig WM; Silwal-Pandit L; Børresen-Dale AL; Creighton CJ; Park JH; Konduri SD; Mukhopadhyay A; Caradori A; Omilian A; Bshara W; Kaipparettu BA; Das GM
J Natl Cancer Inst; 2019 Nov; 111(11):1202-1215. PubMed ID: 30990221
[TBL] [Abstract][Full Text] [Related]
3. Differential association of ESR1 and ESR2 gene variants with the risk of breast cancer and associated features: A case-control study.
Ghali RM; Al-Mutawa MA; Al-Ansari AK; Zaied S; Bhiri H; Mahjoub T; Almawi WY
Gene; 2018 Apr; 651():194-199. PubMed ID: 29414691
[TBL] [Abstract][Full Text] [Related]
4. ERβ splice variant expression in four large cohorts of human breast cancer patient tumors.
Wimberly H; Han G; Pinnaduwage D; Murphy LC; Yang XR; Andrulis IL; Sherman M; Figueroa J; Rimm DL
Breast Cancer Res Treat; 2014 Aug; 146(3):657-67. PubMed ID: 25007965
[TBL] [Abstract][Full Text] [Related]
5. Polymorphisms in genes of the steroid receptor superfamily modify postmenopausal breast cancer risk associated with menopausal hormone therapy.
MARIE-GENICA Consortium on Genetic Susceptibility for Menopausal Hormone Therapy Related Breast Cancer Risk
Int J Cancer; 2010 Jun; 126(12):2935-46. PubMed ID: 19739075
[TBL] [Abstract][Full Text] [Related]
6. High Estrogen Receptor β Expression Is Prognostic among Adjuvant Chemotherapy-Treated Patients-Results from a Population-Based Breast Cancer Cohort.
Elebro K; Borgquist S; Rosendahl AH; Markkula A; Simonsson M; Jirström K; Rose C; Ingvar C; Jernström H
Clin Cancer Res; 2017 Feb; 23(3):766-777. PubMed ID: 27810901
[TBL] [Abstract][Full Text] [Related]
7. ESR1 and ESR2 polymorphisms in the BIG 1-98 trial comparing adjuvant letrozole versus tamoxifen or their sequence for early breast cancer.
Leyland-Jones B; Gray KP; Abramovitz M; Bouzyk M; Young B; Long B; Kammler R; Dell'Orto P; Biasi MO; Thürlimann B; Harvey V; Neven P; Arnould L; Maibach R; Price KN; Coates AS; Goldhirsch A; Gelber RD; Pagani O; Viale G; Rae JM; Regan MM;
Breast Cancer Res Treat; 2015 Dec; 154(3):543-55. PubMed ID: 26590813
[TBL] [Abstract][Full Text] [Related]
8. Estrogen receptor beta--an independent prognostic marker in estrogen receptor alpha and progesterone receptor-positive breast cancer?
Maehle BO; Collett K; Tretli S; Akslen LA; Grotmol T
APMIS; 2009 Sep; 117(9):644-50. PubMed ID: 19703124
[TBL] [Abstract][Full Text] [Related]
9. Estrogen receptor beta (ESR2) polymorphisms in interaction with estrogen receptor alpha (ESR1) and insulin-like growth factor I (IGF1) variants influence the risk of fracture in postmenopausal women.
Rivadeneira F; van Meurs JB; Kant J; Zillikens MC; Stolk L; Beck TJ; Arp P; Schuit SC; Hofman A; Houwing-Duistermaat JJ; van Duijn CM; van Leeuwen JP; Pols HA; Uitterlinden AG
J Bone Miner Res; 2006 Sep; 21(9):1443-56. PubMed ID: 16939403
[TBL] [Abstract][Full Text] [Related]
10. Differential regulation of the inducible nitric oxide synthase gene by estrogen receptors 1 and 2.
Tsutsumi S; Zhang X; Takata K; Takahashi K; Karas RH; Kurachi H; Mendelsohn ME
J Endocrinol; 2008 Nov; 199(2):267-73. PubMed ID: 18753331
[TBL] [Abstract][Full Text] [Related]
11. Small Non-Coding RNA Profiling Identifies miR-181a-5p as a Mediator of Estrogen Receptor Beta-Induced Inhibition of Cholesterol Biosynthesis in Triple-Negative Breast Cancer.
Alexandrova E; Lamberti J; Saggese P; Pecoraro G; Memoli D; Cappa VM; Ravo M; Iorio R; Tarallo R; Rizzo F; Collina F; Cantile M; Bonito MD; Botti G; Nassa G; Weisz A; Giurato G
Cells; 2020 Apr; 9(4):. PubMed ID: 32260128
[TBL] [Abstract][Full Text] [Related]
12. PAM50 breast cancer subtyping by RT-qPCR and concordance with standard clinical molecular markers.
Bastien RR; Rodríguez-Lescure Á; Ebbert MT; Prat A; Munárriz B; Rowe L; Miller P; Ruiz-Borrego M; Anderson D; Lyons B; Álvarez I; Dowell T; Wall D; Seguí MÁ; Barley L; Boucher KM; Alba E; Pappas L; Davis CA; Aranda I; Fauron C; Stijleman IJ; Palacios J; Antón A; Carrasco E; Caballero R; Ellis MJ; Nielsen TO; Perou CM; Astill M; Bernard PS; Martín M
BMC Med Genomics; 2012 Oct; 5():44. PubMed ID: 23035882
[TBL] [Abstract][Full Text] [Related]
13. Association of repeat polymorphisms in the estrogen receptors alpha, beta (ESR1, ESR2) and androgen receptor (AR) genes with the occurrence of breast cancer.
Tsezou A; Tzetis M; Gennatas C; Giannatou E; Pampanos A; Malamis G; Kanavakis E; Kitsiou S
Breast; 2008 Apr; 17(2):159-66. PubMed ID: 17904846
[TBL] [Abstract][Full Text] [Related]
14. ERbeta in breast cancer--onlooker, passive player, or active protector?
Fox EM; Davis RJ; Shupnik MA
Steroids; 2008 Oct; 73(11):1039-51. PubMed ID: 18501937
[TBL] [Abstract][Full Text] [Related]
15. The significance of estrogen receptors in acromegaly: Are they useful as predictors of prognosis and therapy regimen?
Ozturk S; Donmez-Altuntas H; Ozturk F; Kurtsoy A; Gokay F; Simsek Y; Bayram F
Growth Horm IGF Res; 2020 Dec; 55():101337. PubMed ID: 32795827
[TBL] [Abstract][Full Text] [Related]
16. Given breast cancer, is fat better than thin? Impact of the estrogen receptor beta gene polymorphisms.
Borgquist S; Hjertberg M; Henningson M; Ingvar C; Rose C; Jernström H
Breast Cancer Res Treat; 2013 Feb; 137(3):849-62. PubMed ID: 23274843
[TBL] [Abstract][Full Text] [Related]
17. Estrogen receptor genotype and risk of cognitive impairment in elders: findings from the Health ABC study.
Yaffe K; Lindquist K; Sen S; Cauley J; Ferrell R; Penninx B; Harris T; Li R; Cummings SR
Neurobiol Aging; 2009 Apr; 30(4):607-14. PubMed ID: 17889406
[TBL] [Abstract][Full Text] [Related]
18. Impact of estrogen receptor gene polymorphisms and mRNA levels on obesity and lipolysis--a cohort study.
Nilsson M; Dahlman I; Jiao H; Gustafsson JA; Arner P; Dahlman-Wright K
BMC Med Genet; 2007 Dec; 8():73. PubMed ID: 18053221
[TBL] [Abstract][Full Text] [Related]
19. Regulation of submaxillary gland androgen-regulated protein 3A via estrogen receptor 2 in radioresistant head and neck squamous cell carcinoma cells.
Grünow J; Rong C; Hischmann J; Zaoui K; Flechtenmacher C; Weber KJ; Plinkert P; Hess J
J Exp Clin Cancer Res; 2017 Feb; 36(1):25. PubMed ID: 28166815
[TBL] [Abstract][Full Text] [Related]
20. ESR1 gene promoter region methylation in free circulating DNA and its correlation with estrogen receptor protein expression in tumor tissue in breast cancer patients.
Martínez-Galán J; Torres-Torres B; Núñez MI; López-Peñalver J; Del Moral R; Ruiz De Almodóvar JM; Menjón S; Concha A; Chamorro C; Ríos S; Delgado JR
BMC Cancer; 2014 Feb; 14():59. PubMed ID: 24495356
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]